EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,259,109 | -2.8% | 533,055 | +5.8% | 0.00% | – |
| Q2 2023 | $4,382,016 | +231.1% | 503,680 | +11.9% | 0.00% | – |
| Q1 2023 | $1,323,662 | -58.0% | 450,225 | -49.9% | 0.00% | – |
| Q4 2022 | $3,148,292 | -8.2% | 899,512 | +107.4% | 0.00% | – |
| Q3 2022 | $3,431,000 | +7.9% | 433,732 | +7.3% | 0.00% | – |
| Q2 2022 | $3,180,000 | -30.3% | 404,060 | +7.6% | 0.00% | – |
| Q1 2022 | $4,562,000 | +4.3% | 375,470 | +5.1% | 0.00% | – |
| Q4 2021 | $4,374,000 | +38.7% | 357,361 | +18.1% | 0.00% | – |
| Q3 2021 | $3,153,000 | +54.7% | 302,629 | +33.5% | 0.00% | – |
| Q2 2021 | $2,038,000 | – | 226,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |